SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Marilyn Monroe — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientMarilyn Monroe
Date of birth1926-06-01
IdentifiersMRN HR-ML002-SYN-TD; SSN (made up) 000-02-4471
Document date1956-06-24
AuthorJoanna Whitlock, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Transvaginal ultrasound result and gynecology consultation the same day. [S]

History of Present Illness

Ms. Monroe returns nine days after her first visit, on the morning of her transvaginal ultrasound, and is seen the same day by Dr. Okoye of gynecology. She started the continuous combined pill and naproxen after the first visit and has had no bleeding yet; she had one day of nausea on the pill, which passed. She has not taken diphenhydramine and has slept a little better with the sleep routine. Her gonorrhea and chlamydia tests and urinalysis from the first visit were negative. She has had her first session with the behavioral health clinician. She asks whether she will need an operation, and whether this will stop her from having children. She has had no thoughts of suicide or self-harm. [S]

ElementDetail
TreatmentContinuous combined pill and naproxen for nine days; no bleeding
PainPelvic ache on most days, less than before
First-visit testsGonorrhea, chlamydia and urinalysis negative
SleepNo diphenhydramine; a little better
Her questionsSurgery, and whether she can have children

Review of Systems

SystemResultFinding
GastrointestinalPositiveOne day of nausea on starting the pill; no bowel pain this week
GenitourinaryPositiveLow pelvic ache on most days; no bleeding or urinary symptoms
NeurologicalNegativeNo headaches or visual aura
PsychiatricPositiveStill low but hopeful about the plan; no thoughts of suicide or self-harm

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Naproxen 500 mg oral tablet, one tablet by mouth twice daily with food, from two days before an expected bleed until the third day, and for pain flares; no more than 10 days a monthOne tablet by mouth twice daily with food when needed for pelvic painOral route1956-06-15activeS
Ethinyl estradiol 0.02 mg and norethindrone acetate 1 mg oral tablet, one tablet by mouth daily, taken continuously without a pill-free weekOne tablet by mouth daily, continuouslyOral route1956-06-15activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1956-06-24Body height166cmS
1956-06-24Body weight56.2kgS
1956-06-24Body mass index (BMI) [Ratio]20.4kg/m2S
1956-06-24Systolic blood pressure110mm[Hg]S
1956-06-24Diastolic blood pressure70mm[Hg]S
1956-06-24Heart rate74/minS
1956-06-24Respiratory rate14/minS
1956-06-24Body temperature36.6CelS
1956-06-24Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1956-06-24Mullerian inhibiting substance [Mass/volume] in Serum or Plasma2.6ng/mLTypical range at ages 30 to 34; a low value suggests a smaller ovarian reserve but does not predict natural fertilityNormalS

Physical Exam

Vital signs recorded on 1956-06-24; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 110/70, pulse 74; weight 56.2 kg
AbdomenSoft; mild left lower quadrant tenderness; no mass
PelvicExamined by Dr. Okoye: tender, slightly fixed retroverted uterus; fullness and tenderness in the left adnexa; thickened, tender left uterosacral ligament; no nodule felt in the rectovaginal septum
PsychiatricAnxious about fertility; organized; tearful briefly; no psychotic features

Problems

ProblemClinical statusVerificationCodeProvenance
Severe painful periods since her teens, worse over the past three years, with pelvic pain between periods, deep pain with intercourse, and painful bowel movements during periods; she misses work for two or three days each cycle. Tender, slightly fixed retroverted uterus with tenderness and fullness in the left adnexa and along the left uterosacral ligament. Suspected endometriosis; transvaginal ultrasound and gynecology consultation bookedresolvedconfirmed N94.6S — Synthetic presenting problem linked to her documented endometriosis; superseded by the diagnosis at the consultation.
Endometriosis: a 3.4 cm left ovarian endometrioma on transvaginal ultrasound, with a tender, thickened left uterosacral ligament and no deep nodule of the bowel or bladder seen; diagnosed from imaging and examination without surgery, as the ESHRE guideline allows. Synthetic modern episode linked to her documented endometriosisactiveconfirmed N80.102S — Synthetic modern diagnosis made at the gynecology consultation; depth is unspecified because no surgery was done.
Major depressive disorder, single episode, moderate: about two months of low mood, poor sleep on painful nights, low energy, guilt about missed work, and poor concentration (PHQ-9 12, item 9 scored 0; GAD-7 8); Mood Disorder Questionnaire negative; no thoughts of suicide or self-harmactiveconfirmed F32.1S — Synthetic modern diagnosis; the historical and retrospective mental-health accounts are not coded.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyPelvic pain score (0 to 10), pain with intercourse and bowel movements, and missed working daysEvery visitCompleted todayAche on most days, less than before; no bowel pain this week; no missed work since the first visit
Self-managementBleeding pattern on continuous suppressionEvery visitCompleted todayNo bleeding in nine days
Medication safetyCombined pill: adherence, side effects, and reasons to stop estrogen (migraine with aura, high blood pressure, clot symptoms, smoking)Every visit, with blood pressureCompleted todayTaken daily; one day of nausea; blood pressure 110/70; no migraine with aura, clot symptoms or smoking
Medication safetyNaproxen: days used each month, and stomach or kidney symptomsEvery visitCompleted todayNaproxen on four days, with food; no stomach pain
Medication safetyNo opioid, benzodiazepine, or sleep-medicine accumulation; prescription monitoring programAt the start, then every visit while pain is activeCompleted todayNo opioid or sedative since the first visit; diphenhydramine stopped; the prescription monitoring program was checked at the first visit
ImagingTransvaginal ultrasound: endometrioma size and deep diseaseAt diagnosis; repeat at about four months on medical treatment, then yearly or if symptoms changeCompleted today3.4 by 2.9 cm typical left endometrioma; no deep nodules; no adenomyosis
LaboratoryCA-125Not used to diagnose endometriosisNot indicatedThe ESHRE guideline advises against CA-125 for diagnosis; the ultrasound features are typical of an endometrioma
LaboratoryOvarian reserve (anti-Mullerian hormone)For fertility counseling and before any ovarian surgeryCompleted today2.6 ng/mL, typical for her age; antral follicles 9 right and 6 left
ExaminationPelvic examinationAt diagnosis, and when pain persists or changesCompleted todayLeft adnexal and uterosacral tenderness; no rectovaginal nodule
ReferralSurgical evaluation (laparoscopic excision)If pain does not respond to medical treatment, the cyst grows, or imaging is atypicalCompleted todayDiscussed by Dr. Okoye; not needed now; kept in reserve
Self-managementPregnancy intention and fertility planEvery visitCompleted todayWants a pregnancy in about a year; the fertility plan agreed today
SurveyDepression measure (PHQ-9)Monthly during acute treatment, every 2 to 4 weeks in continuation, then periodicallyUp to datePHQ-9 12 nine days ago; next in about four weeks
SurveyAnxiety measure (GAD-7)At diagnosis and with each depression measureUp to dateGAD-7 8 nine days ago
SurveySuicide-risk review, safety plan, lethal means, and the 988 Suicide & Crisis LifelineEvery visitCompleted todayNo thoughts of suicide or self-harm; safety plan reviewed; leftover medicines returned to a pharmacy
Self-managementCognitive behavioral therapy engagementWeekly for the first month, then every two weeksCompleted todayFirst session done
Self-managementSleep without sedativesEvery visitCompleted todayRegular bedtime; no diphenhydramine

Goal progress:

Guideline basis: Practice Bulletin No. 114: Management of Endometriosis (2010); ESHRE guideline: endometriosis (2022); Chronic Pelvic Pain: ACOG Practice Bulletin, Number 218 (2020); CDC Clinical Practice Guideline for Prescribing Opioids for Pain, United States, 2022 (2022); U.S. Medical Eligibility Criteria for Contraceptive Use, 2024 (2024); U.S. Selected Practice Recommendations for Contraceptive Use, 2024 (2024); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026)

Follow-up: Behavioral health weekly. Preventive visit in about eight weeks. Endometriosis review in about three months with the pain score, PHQ-9 and GAD-7, and a repeat ultrasound at about four months. Next scheduled visit 1956-08-17: periodic adult preventive visit with pregnancy planning. [S]